Clinical Trial Update: Diabetes Treatment With Glucobay in Combination With Sulfonylurea

View source ↗

Summary

Bayer conducted a clinical trial evaluating Glucobay (acarbose) in combination with a sulfonylurea for type 2 diabetes. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glucobay (acarbose)
• Sulfonylurea (sulfonylurea)

Snippet

Sponsor: Bayer | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED